{"title":"从临床试验最小起始剂量和日本抗体药物微剂量批准最小临床剂量的考虑","authors":"Yasuhiro Suzuki, K. Matsuno, A. Inano","doi":"10.3999/jscpt.51.1","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":21491,"journal":{"name":"Rinsho Yakuri\\/japanese Journal of Clinical Pharmacology and Therapeutics","volume":"32 1","pages":"1-10"},"PeriodicalIF":0.0000,"publicationDate":"2020-01-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Consideration from the Smallest Starting Dose Used in Clinical Trials and the Approved Minimum Clinical Dose for Microdose of Antibody Pharmaceuticals in Japan\",\"authors\":\"Yasuhiro Suzuki, K. Matsuno, A. Inano\",\"doi\":\"10.3999/jscpt.51.1\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":21491,\"journal\":{\"name\":\"Rinsho Yakuri\\\\/japanese Journal of Clinical Pharmacology and Therapeutics\",\"volume\":\"32 1\",\"pages\":\"1-10\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2020-01-31\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Rinsho Yakuri\\\\/japanese Journal of Clinical Pharmacology and Therapeutics\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.3999/jscpt.51.1\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Rinsho Yakuri\\/japanese Journal of Clinical Pharmacology and Therapeutics","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3999/jscpt.51.1","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Consideration from the Smallest Starting Dose Used in Clinical Trials and the Approved Minimum Clinical Dose for Microdose of Antibody Pharmaceuticals in Japan